Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer vaccine
Biotech
BioNTech’s chief strategy officer heads for the exit
Chief strategy officer Ryan Richardson is set to leave the company at the end of September to "pursue new professional opportunities."
Nick Paul Taylor
Jul 17, 2025 10:55am
OSE shares 65% OS rate behind cancer vaccine's phase 2 win
Jun 3, 2025 7:05am
Apollomics tags out of TYG oncology pact to cut costs
Apr 4, 2025 6:45am
Otsuka gives cancer candidates the kiss-off on strategic grounds
Feb 14, 2025 5:30am
Cancer vaccine prevents kidney cancer comeback in small trial
Feb 6, 2025 3:00pm
GSK and Oxford University ink cancer vaccine research pact
Jan 26, 2025 7:01pm
